Zimmer Biomet Holdings, Inc. (ZBH) Q4 2022 Earnings Results

Zimmer Biomet Beats on EPS, Stock Up 1.6%

Zimmer Biomet's earnings report shows a positive surprise on EPS, which contributed to a 1.6% increase in stock price. The company is navigating market challenges while focusing on innovation and growth. Investors may view this as a sign of resilience in a competitive landscape.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$1.88	N/A	+2.62%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Overall, management expressed a cautious optimism about the future. They acknowledged current market challenges but are focused on innovation and growth strategies.

Management highlighted strong operational performance despite market challenges.

They emphasized their commitment to innovation and improving patient outcomes.

The team remains focused on strategic initiatives to drive growth.

Zimmer Biomet Beats on EPS, Stock Up 1.6%

Key numbers

Management commentary

Zimmer Biomet Holdings, Inc.

More earnings this week

Zimmer Biomet Beats on EPS, Stock Up 1.6%

Key numbers

Management commentary